SLC7A11 and cancer: For instance, numerous studies have demonstrated that targeting cystine transporter SLC7A11 is a potential means of inducing ferroptosis for therapeutic purposes, either alone or in combination with other drugs, radiotherapy, or immunotherapy, with particular promise for the treatment of cancers and neurodegenerative diseases.